Molecure S.A.
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
MOC | WAR
Overview
Corporate Details
- ISIN(s):
- PLONCTH00011
- LEI:
- 2594003L11V38ZCVKZ09
- Country:
- Poland
- Address:
- Warszawa Żwirki i Wigury 101, 02-089 Warszawa
- Website:
- https://molecure.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Molecure S.A. is a clinical-stage biotechnology company that discovers and develops first-in-class small molecule drugs. The company focuses on treating diseases with high unmet medical needs, primarily in oncology and inflammatory and fibrotic conditions. Leveraging its in-house medicinal chemistry and biology capabilities, Molecure targets novel and unexplored protein and mRNA targets through its proprietary discovery platform. Its business model involves advancing a diverse pipeline of drug candidates to the clinical stage before engaging in licensing agreements for late-stage development and commercialization. The company was formerly known as OncoArendi, changing its name in March 2022.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-27 07:11 |
Quarterly Report
Skonsolidowany raport Grupy Kapitałowej za III kwartał 2025 roku
|
Polish | 2.6 MB | ||
| 2025-10-22 19:50 |
Report Publication Announcement
Zmiana terminu publikacji raportu za III kwartał 2025 roku. - Content (PL)
|
Polish | 917 bytes | ||
| 2025-10-21 16:00 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym…
|
Polish | 2.0 KB | ||
| 2025-10-21 15:46 |
Post-Annual General Meeting Information
Treść powziętych uchwał
|
Polish | 229.8 KB | ||
| 2025-10-21 15:46 |
Post-Annual General Meeting Information
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie w dniu 21 paździer…
|
Polish | 686 bytes | ||
| 2025-09-30 07:56 |
Audit Report / Information
Raport z przeglądu SSF 30.06.2025
|
Polish | 236.4 KB | ||
| 2025-09-30 07:56 |
Audit Report / Information
Raport z przeglądu JSF 30.06.2025
|
Polish | 233.4 KB | ||
| 2025-09-30 07:56 |
Management Discussion and Analysis
Sprawozdanie Zarządu z działalności Molecure S.A. 30.06.2025
|
Polish | 1.5 MB | ||
| 2025-09-30 07:56 |
Interim Report
Skonsolidowane Sprawozdanie Finansowe Molecure S.A. 30.06.2025
|
Polish | 1.1 MB | ||
| 2025-09-30 07:56 |
Interim Report
Jednostkowe Sprawozdanie Finansowe Molecure S.A. 30.06.2025
|
Polish | 1.2 MB | ||
| 2025-09-26 17:16 |
Regulatory News Service
Informacja o pozytywnej ocenie wniosku Spółki w ramach ścieżki "SMART" - Projek…
|
Polish | 2.5 KB | ||
| 2025-09-23 15:18 |
Pre-Annual General Meeting Information
Zaktualizowane projekty uchwał
|
Polish | 225.0 KB | ||
| 2025-09-23 15:18 |
Pre-Annual General Meeting Information
Aktualizacja Zarządu dotycząca projektu Uchwały Nadzwyczajnego Walnego Zgromadz…
|
Polish | 4.9 KB | ||
| 2025-09-22 20:37 |
Pre-Annual General Meeting Information
Załącznik - Projekty uchwał
|
Polish | 227.6 KB | ||
| 2025-09-22 20:37 |
Pre-Annual General Meeting Information
Projekty uchwał Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
|
Polish | 469 bytes |
Automate Your Workflow. Get a real-time feed of all Molecure S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Molecure S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Molecure S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
